Oramed Pharmaceuticals (ORMP) Stock Highlights

2.37 | -4.82%

2024-12-21 06:54:00

Oramed Pharmaceuticals Inc is a pharmaceutical company which is engaged in the research and development of pharmaceutical solutions, including an oral insulin capsule to be used for the treatment of individuals with diabetes, and the use of orally ingestible capsules or pills for delivery of other polypeptides. The ORMD-0801 is a proprietary product which is an orally ingestible insulin capsule for the treatment of diabetes. Its other product includes Oral Glucagon-like peptide-1 which is an incretin hormone, a type of gastrointestinal hormone that stimulates the secretion of insulin from the pancreas.

Statistics

Range Today

2.37 2.49

Volume Today 100.6K

Range 1 Year

2 3.67

Volume 1 Year 35.52M

Range 3 Year

1.67 15.8

Volume 3 Year 425.45M

Range 10 Year

1.67 31.54

Volume 10 Year 768.3M

Highlights

Market Capitalization 97.03M (small)

Floating Shares 34.91M

Current Price 2.37

Price To Earnings 4.72

Price To Book 0.57

Earnings Per Share 0.5

Payout Ratio 0%

Performance

Latest -4.82%

1 Month +4.41%

3 Months -3.27%

6 Months +8.22%

1 Year +6.28%

3 Years -84.32%

5 Years -58.42%

10 Years -56.03%

Benchmarks

Market Capitalization

241 / 368

Gross Profits

113 / 278

Total Revenue

224 / 300

Total Rank

219 / 368

Free Cashflow

104 / 352

Performance 5 years

182 / 368

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.